Calcineurin is involved in the early activation of NMDA‐mediated cell death in mutant huntingtin knock‐in striatal cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neurochemistry

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2008.05252.xPMID 18221365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling.

  2008cited by this paper
• NMDA Receptor Function and NMDA Receptor-Dependent Phosphorylation of Huntingtin Is Altered by the Endocytic Protein HIP1

  2007cited by this paper
• N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.

  2007cited by this paper
• Calcineurin Potentiates the Activation of Procaspase-3 by Accelerating Its Proteolytic Maturation*

  2007cited by this paper
• Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors

  2006cited by this paper
• Generation of constitutively active calcineurin by calpain contributes to delayed neuronal death following mouse brain ischemia

  2006cited by this paper
• Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells

  2006cited by this paper
• Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.

  2006cited by this paper
• Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease.

  2006cited by this paper
• Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.

  2006influential reference
• The death-associated protein kinases: structure, function, and beyond.

  2006cited by this paper
• Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421

  2006influential reference
• Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases

  2005cited by this paper
• Phosphorylation of Arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced Toxicity by Rescuing Proteasome Impairment*

  2005cited by this paper
• HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.

  2005cited by this paper
• Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in striatal neurons in vivo.

  2005cited by this paper
• Death-associated Protein Kinase Is Activated by Dephosphorylation in Response to Cerebral Ischemia*

  2005influential reference
• Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain.

  2005cited by this paper
• Brain‐derived neurotrophic factor prevents changes in Bcl‐2 family members and caspase‐3 activation induced by excitotoxicity in the striatum

  2005cited by this paper
• Brief exposure to NMDA produces long‐term protection of cerebellar granule cells from apoptosis

  2005cited by this paper
• Deranged neuronal calcium signaling and Huntington disease.

  2004cited by this paper
• Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration*

  2004cited by this paper
• Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

  2004cited by this paper
• Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release.

  2004cited by this paper
• FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures.

  2004influential reference
• Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity

  2004cited by this paper
• The serum‐ and glucocorticoid‐induced kinase SGK inhibits mutant huntingtin‐induced toxicity by phosphorylating serine 421 of huntingtin

  2004cited by this paper
• Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.

  2004cited by this paper
• Calcineurin-mediated BAD Ser155 dephosphorylation in ammonia-induced apoptosis of cultured rat hippocampal neurons.

  2004cited by this paper
• Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells*

  2003cited by this paper
• Cyclosporin A prevents calpain activation despite increased intracellular calcium concentrations, as well as translocation of apoptosis‐inducing factor, cytochrome c and caspase‐3 activation in neurons exposed to transient hypoglycemia

  2003influential reference
• The calpain system.

  2003cited by this paper
• Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration Induced In Vivo by 3-Nitropropionate: Implications for Huntington's Disease

  2003cited by this paper
• TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase

  2002cited by this paper
• Regulation of DARPP‐32 dephosphorylation at PKA‐ and Cdk5‐sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase‐2A

  2002cited by this paper
• Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.

  2002cited by this paper
• Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntington's disease transgenic mice.

  2002cited by this paper
• TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase.

  2002cited by this paper
• Brain‐derived neurotrophic factor (BDNF) mediates bone morphogenetic protein‐2 (BMP‐2) effects on cultured striatal neurones

  2001cited by this paper
• Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Calcineurin-Mediated BAD Dephosphorylation Activates the Caspase-3 Apoptotic Cascade in Traumatic Spinal Cord Injury

  2000cited by this paper
• Involvement of Activated Caspase‐3‐Like Proteases in N‐Methyl‐D‐Aspartate‐Induced Apoptosis in Cerebrocortical Neurons

  2000cited by this paper
• Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

  2000cited by this paper
• Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells.

  2000cited by this paper
• Calcineurin: form and function.

  2000cited by this paper
• Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts.

  2000cited by this paper
• Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.

  1999cited by this paper
• High Level Calcineurin Activity Predisposes Neuronal Cells to Apoptosis*

  1999influential reference
• Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity.

  1999influential reference
• N‐Methyl‐d‐Aspartate Receptor Desensitisation Is Neuroprotective by Inhibiting Glutamate‐Induced Apoptotic‐Like Death

  1998cited by this paper
• Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat

  1998cited by this paper
• Neuroprotective Actions of FK506 in Experimental Stroke: In Vivo Evidence against an Antiexcitotoxic Mechanism

  1997cited by this paper
• Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction.

  1997cited by this paper
• Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death

  1996influential reference
• Calcineurin functions in Ca(2+)-activated cell death in mammalian cells

  1995cited by this paper
• Delayed antagonism of calpain reduces excitotoxicity in cultured neurons.

  1995cited by this paper
• 3‐Nitropropionic Acid Toxicity in the Striatum

  1994cited by this paper
• Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.

  1994cited by this paper
• Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.

  1993cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

  1991cited by this paper
• Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism.

  1990cited by this paper
• Excitotoxic injury of the neostriatum: a model for Huntington's disease.

  1990cited by this paper
• Morphological characterization of the rat striatal neurons expressing calcineurin immunoreactivity.

  1987cited by this paper
• Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

  1986cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper

• Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function

  2023cites this paper
• Spatial proteomic alterations detected via MALDI-MS imaging implicate neuronal loss in a Huntington's disease mouse (YAC128) brain.

  2022cites this paper
• Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review

  2022cites this paper
• TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs

  2022cites this paper
• Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy

  2022cites this paper
• Unraveling the Spatiotemporal Distribution of VPS13A in the Mouse Brain

  2021cites this paper
• Altered microRNA expression in animal models of Huntington’s disease and potential therapeutic strategies

  2021influential citation
• Neuron type‐specific increase in lamin B1 contributes to nuclear dysfunction in Huntington’s disease

  2020cites this paper
• How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington’s Disease? A Comprehensive Review

  2020cites this paper
• Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity

  2020cites this paper
• Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways.

  2019cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington’s Disease

  2018cites this paper
• Cause or compensation?—Altered neuronal Ca2+ handling in Huntington's disease

  2018cites this paper
• A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders

  2018cites this paper
• 20 Don ’ t Take Away My P : Phosphatases as Therapeutic Targets in Huntington ’ s Disease

  2018influential citation
• Nous mecanismes implicats en els dèficits transcripcionals i la pèrdua del bdnf en la malaltia de huntington: descripció de noves dianes terapèutiques

  2018cites this paper
• Human alpha 1-antitrypsin protects neurons and glial cells against oxygen and glucose deprivation through inhibition of interleukins expression.

  2018cites this paper
• Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

  2018cites this paper
• Pathogenesis of Huntington’s Disease: How to Fight Excitotoxicity and Transcriptional Dysregulation

  2017influential citation
• Reduced cell size, chromosomal aberration and altered proliferation rates are characteristics and confounding factors in the STHdh cell model of Huntington disease

  2017cites this paper
• MAP2 Splicing is Altered in Huntington's Disease

  2017cites this paper
• Evaluation of neuroprotective effect of flupirtine in brain of albino rats

  2016cites this paper
• The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity

  2016cites this paper
• Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF

  2016cites this paper
• Actin Filaments Are Involved in the Coupling of V0-V1 Domains of Vacuolar H+-ATPase at the Golgi Complex*

  2016cites this paper
• Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.

  2016cites this paper
• RegulationSer/Thr Protein Phosphatases in Cell Death

  2015cites this paper
• The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway

  2015cites this paper
• Age Associated Sleep Loss: A Trigger For Alzheimer's Disease

  2015cites this paper
• The CB 1 cannabinoid receptor signals striatal neuroprotection via a PI 3 K / Akt / mTORC 1 / BDNF pathway

  2015cites this paper
• Early Down-Regulation of PKCδ as a Pro-Survival Mechanism in Huntington’s Disease

  2014cites this paper
• Die Rolle von Mangan bei neurodegenerativen Erkrankungen

  2014cites this paper
• Imbalance of p75NTR/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies

  2013cites this paper
• Surveying the Landscape of Huntington's Disease Mechanisms, Measurements, and Medicines

  2013cites this paper
• Grb2 Is Regulated by Foxd3 and Has Roles in Preventing Accumulation and Aggregation of Mutant Huntingtin

  2013cites this paper
• FK506 attenuates intracerebroventricular streptozotocin-induced neurotoxicity in rats.

  2013cites this paper
• The transcription factor Elk-1 belongs to the ternary complex factor family of erythroblast transformation specific (ETS)-

  2012cites this paper
• Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways

  2012cites this paper
• Sleep loss, brain vulnerability and psychopathology: experimental studies on the neurobiological consequences of chronic sleep restriction in rats

  2012cites this paper
• Activation of Elk‐1 participates as a neuroprotective compensatory mechanism in models of Huntington’s disease

  2012cites this paper
• Shaping the role of mitochondria in the pathogenesis of Huntington's disease

  2012cites this paper
• Novel Ser / Thr Protein Phosphatases in Cell

  2012cites this paper
• Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease

  2012influential citation
• Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model.

  2012cites this paper
• Novel Ser/Thr protein phosphatases in cell death regulation.

  2012cites this paper
• CHARACTERIZING THE FUNCTION OF HUNTINGTIN IN THE CELL STRESS RESPONSE AS A TARGET FOR DRUG DISCOVERY IN HUNTINGTON’S DISEASE

  2012cites this paper
• Regulation of miR-146a by RelA/NFkB and p53 in STHdhQ111/HdhQ111 Cells, a Cell Model of Huntington's Disease

  2011cites this paper
• Role of manganese in neurodegenerative diseases.

  2011cites this paper
• Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity

  2011cites this paper
• Signaling pathways involved in enhanced NMDA receptor-dependent excitotoxicity in a mouse model of Huntington disease

  2011cites this paper
• Micro RNA -214,-150,-146a and-125b target Huntingtin gene

  2011cites this paper
• DEVELOPMENT OF NEUROPROTECTIVE STRATEGIES WITH BDNF IN HUNTINGTON ' S DISEASE

  2011cites this paper
• FK506 ameliorates cell death features in Huntington's disease striatal cell models.

  2011cites this paper
• Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease

  2010influential citation
• Phosphorylation of Huntingtin at Ser421 in YAC128 Neurons Is Associated with Protection of YAC128 Neurons from NMDA-Mediated Excitotoxicity and Is Modulated by PP1 and PP2A

  2010cites this paper
• Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli

  2010cites this paper
• Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.

  2010cites this paper
• Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington

  2010cites this paper
• Retraction Note to: Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death

  2009cites this paper
• BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.

  2009cites this paper
• Stress-induced Switch in Numb Isoforms Enhances Notch-dependent Expression of Subtype-specific Transient Receptor Potential Channel*

  2009cites this paper
• Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death

  2009cites this paper
• Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.

  2009cites this paper
• Interaction of Postsynaptic Density Protein-95 with NMDA Receptors Influences Excitotoxicity in the Yeast Artificial Chromosome Mouse Model of Huntington's Disease

  2009cites this paper
• Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease

  2009cites this paper
• Dopaminergic and Glutamatergic Signaling Crosstalk in Huntington's Disease Neurodegeneration: The Role of p25/Cyclin-Dependent Kinase 5

  2008influential citation
• Analysis of transgenic mouse models of Huntington's disease

  2008cites this paper
• Actin Filaments Are Involved in the Coupling of V 0 -v 1 Domains of Vacuolar H Recipient of a Predoctoral Fellowship from the Spanish Ministerio De Econo- Mia Y Competitividad. 2

  year unknowncites this paper